ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631477 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631477; 2) Community: the network communities that were significantly associated with the response to NSC 631477; 3) Molecule: the relationships between components within communities and NSC 631477; 4) MDR: the compounds that were significantly associated with the NSC 631477.

NSC Compound Enrichment Correlation
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 4.20634348588214e-005 0.34202922
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 4.20634348588214e-005 0.40538943
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 4.2063434858822e-005 0.35364241
NSC 169774 Bromocriptine methanesulfonate 4.2063434858822e-005 0.46211289
NSC 617989 3-Deazaneplanocin, hydrochloride 4.2063434858822e-005 0.55942889
NSC 621336 Null 4.9327988091187e-006 0.3695075
NSC 108165 CP 12252-1 6.4414835994983e-006 0.45177826
NSC 345647 CHAETOCHROMIN 6.4414835994983e-006 0.10029272
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 6.67967536140749e-005 -0.28634896
NSC 651605 Null 6.67967536140751e-005 0.27243008
Total:162  Current:161    [First] [Prev] [Next] [Last]